Vaccine-induced immunity in early life

Vaccine

Volumn 31, Issue 21, 2013, Pages 2481-2482

  Kollmann, Tobias R ^a   Levy, Ofer ^b,c   Hanekom, Willem ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

DRUG SAFETY; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; SEROCONVERSION;

AGE FACTORS; HUMANS; IMMUNITY, INNATE; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MEASLES VACCINE; VACCINES;

EID: 84877801247     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.025     Document Type: Editorial

References (4)

1. WHO Causes of Child Mortality for the Year 2010 2013, WHO, Geneva: Global Health Observatory.
2. Levine M.M. "IDEAL" vaccines for resource poor settings. Vaccine 2011, 29(Suppl. 4):D116-D125.
3. Clemens J., Holmgren J., Kaufmann S.H., Mantovani A. Ten years of the global alliance for vaccines and immunization: challenges and progress. Nat Immunol 2010, 11:1069-1072.
4. Levine M.M., Robins-Browne R. Vaccines, global health and social equity. Immunol Cell Biol 2009, 87:274-278.